Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HEALIUS LIMITED Director's Dealing 2022

Sep 1, 2022

65058_rns_2022-09-01_1e19fe0b-4c16-4c2d-9031-0f432f6d2eca.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entityHEALIUS LIMITED Name of entityHEALIUS LIMITED
ABN 24 064 530 516

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Dr Paul Francis Jones
Date of last notice 24 February2022

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Part 1 - Change of director’s relevant interests Part 1 - Change of director’s relevant interests in securities in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraphdisclosed in this art (i) of the definition of “notifiable interest of a director” should be
p.
Direct or indirect interest Direct
N/A
02 September 2022
4,016 NED Share RightsDr Paul Jones12,623 Ordinary Shares*Dr Paul Jones40,588 Ordinary SharesPannly Pty Ltd ATF JonesFamily Trust*Shares are subject to a holding lock as “Restricted Shares” underthe NED Share Plan
Fully paid Ordinary Shares
4,016
N/A
$20,000 cash equivalent using the volume weightedaverage price of Ordinary Shares over the five businessdays immediately following the Healius Limited AnnualGeneral Meeting on 21 October 2021, being $4.98.
  • See chapter 19 for defined terms. Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held afterchange 16,639 Ordinary Shares*Dr Paul Jones40,588 Ordinary SharesPannly Pty Ltd ATFJones Family Trust*Shares are subject to a holding lock as “Restricted Shares”under the NED Share Plan
Nature of changeExample: on-market trade, off-market trade,exercise of options, issue of securities underdividend reinvestment plan, participation in buy-back Vesting of remaining 50% of NED Share Rights issued inrespect of FY 2022 into Ordinary Shares (restricted) underthe NED Share Plan.

Part 2 – Change of director’s interests in contracts Not applicable

Part 3 –[+] Closed period

art 3 –+Closed period
Were the interests in the securities or contractsdetailed above traded during a+closed period whereprior written clearance was required? Not applicable
If so, was prior written clearance provided to allow thetrade to proceed during this period? Not applicable
If prior written clearance was provided, on what datewas this provided? Not applicable

Authorised by the Company Secretary.

Charles Tilley Group Company Secretary 02 September 2022

  • See chapter 19 for defined terms. Appendix 3Y Page 2